TMO — THERMO FISHER SCIENTIFIC INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
Measured signals that fired on TMO
| date | signal | measured base rate |
|---|---|---|
| 2026-08-20 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-13 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-15 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-25 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-03 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-05-28 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-19 | Britt Lisa P. Sr. VP and Chief HR Officer | Open-market sale | 11.4K | 613.12 | 7.0M |
| 2026-08-19 | Britt Lisa P. Sr. VP and Chief HR Officer | Option exercise | 11.4K | 418.32 | 4.8M |
| 2026-08-11 | Shafer Michael D Executive Vice President | Open-market sale 10b5-1 plan | 14.3K | 600.00 | 8.6M |
| 2026-08-11 | Shafer Michael D Executive Vice President | Open-market sale 10b5-1 plan | 11.2K | 600.00 | 6.7M |
| 2026-08-11 | Shafer Michael D Executive Vice President | Option exercise 10b5-1 plan | 14.3K | 418.32 | 6.0M |
| 2026-08-11 | Shafer Michael D Executive Vice President | Option exercise 10b5-1 plan | 11.2K | 309.63 | 3.5M |
| 2026-08-07 | CASPER MARC N Chairman & CEO | Open-market sale 10b5-1 plan | 1.0K | 584.41 | 604.9K |
| 2026-08-07 | CASPER MARC N Chairman & CEO | Open-market sale 10b5-1 plan | 945 | 586.52 | 554.3K |
| 2026-08-07 | CASPER MARC N Chairman & CEO | Open-market sale 10b5-1 plan | 530 | 585.44 | 310.3K |
| 2026-08-07 | CASPER MARC N Chairman & CEO | Open-market sale 10b5-1 plan | 522 | 589.52 | 307.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 15.0B | 30.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.9B | 24.3M |
| STATE STREET CORP | 8.2B | 16.7M |
| MORGAN STANLEY | 5.3B | 10.9M |
| FMR LLC | 5.3B | 10.8M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.1B | 8.4M |
| FRANKLIN RESOURCES INC | 3.3B | 6.8M |
| Capital World Investors | 3.3B | 6.6M |
| JPMORGAN CHASE & CO | 3.3B | 6.8M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.0B | 6.2M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED) · 2026-08-20 · benzinga
- Thermo Fisher Beat Estimates by $300 Million in Q2. Is the Recovery Finally Here? - TIKR.com · 2026-08-12 · TIKR.com
- $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today · 2026-08-11 · benzinga
- Thermo Fisher Says India Is One Of Its Fastest-Growing Markets · 2026-08-11 · benzinga
- Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost - Reuters · 2026-08-10 · Reuters
Others in Industrials
Ask the AI about TMO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →